Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000090325

Apexbio Technology LLC Abiraterone acetate 154229-18-2 5mg
SDP

Catalog No. 5000090325
Encompass_Preferred

Abiraterone acetate (CAS 154229-18-2) is the 3 -acetate ester prodrug of abiraterone a steroidal inhibitor of androgen biosynthesis Abiraterone selectively and irreversibly inhibits cytochrome P450 17 -hydroxylase/17 20-lyase (CYP17) an enzyme critical for the synthesis of androgen and cortisol This inhibition occurs via covalent binding and is characterized by a reported IC50 of 72 nM Abiraterone s potency attributed to its 3-pyridyl substituent exceeds that of ketoconazole by 10- to 30-fold in CYP17 inhibition Abiraterone acetate is widely used in research exploring mechanisms and interventions for castration-resistant prostate cancer

Catalog No. 50-000-90325 Supplier Apexbio Technology LLC Supplier No. A82025
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Abiraterone acetate (CAS 154229-18-2) is the 3 -acetate ester prodrug of abiraterone a steroidal inhibitor of androgen biosynthesis Abiraterone selectively and irreversibly inhibits cytochrome P450 17 -hydroxylase/17 20-lyase (CYP17) an enzyme critical for the synthesis of androgen and cortisol This inhibition occurs via covalent binding and is characterized by a reported IC50 of 72 nM Abiraterone s potency attributed to its 3-pyridyl substituent exceeds that of ketoconazole by 10- to 30-fold in CYP17 inhibition Abiraterone acetate is widely used in research exploring mechanisms and interventions for castration-resistant prostate cancer

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.